Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

ClinicalTrials.gov 24,857 recruiting now free trial finder

Find a clinical trial that's recruiting now

Search 24,857 actively recruiting US clinical trials by condition, drug, or state, each entry links straight to its NIH ClinicalTrials.gov record so you can check eligibility and contact the study team.

24,857
trials recruiting now
14%
of all US trials open to enrollment
52
states with recruiting sites

A trial is listed as recruiting when its sponsor has marked it open to new participants on the public registry. Type a condition or drug name (for example, "breast cancer" or "pembrolizumab") to narrow the list, and add a state to find studies with a site near you. Results are ordered with the most relevant recruiting studies first; each card shows the study phase and enrollment target, and opens the full record, including eligibility criteria and contact details, on ClinicalTrials.gov.

Popular conditions

Breast CancerHealthyObesityProstate CancerDepressionCancerHIV InfectionsHypertension

100 trials found

Recruiting 400,000 target

Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)

VA Office of Research and Development

NCT06160128
Recruiting 200,000 target

Connect for Cancer Prevention Study (Connect)

National Cancer Institute (NCI)

NCT04609072
Recruiting NA 75,000 target

War on Melanoma™ Public Health & Education Campaign

OHSU Knight Cancer Institute

NCT04611568
Recruiting 30,000 target

Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts

Mayo Clinic

NCT06271291
Recruiting NA 27,500 target

Identifying and Caring for Individuals With Inherited Cancer Syndrome

OHSU Knight Cancer Institute

NCT04494945
Recruiting Phase 3 20,000 target

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

UMC Utrecht

NCT02735707
Recruiting NA 17,800 target

Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction

Swedish Medical Center

NCT07108660
Recruiting NA 13,000 target

Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

Washington University School of Medicine

NCT05991453
Recruiting 10,000 target

Comprehensive HHT Outcomes Registry of the United States (CHORUS)

Cure HHT

NCT06259292
Recruiting NA 10,000 target

VAPORHCS/OHSU J: MRI and Devices

Oregon Health and Science University

NCT03915015
Recruiting 10,000 target

Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors

National Cancer Institute (NCI)

NCT03739827
Recruiting NA 8,946 target

Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

Dartmouth-Hitchcock Medical Center

NCT05612347
Recruiting 7,500 target

MYLUNG Consortium Part 3: Observational Study

US Oncology Research

NCT05885698
Recruiting 7,000 target

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Adela

NCT05366881
Recruiting Phase 3 6,700 target

Pediatric Dose Optimization for Seizures in Emergency Medical Services

Stanford University

NCT05121324
Recruiting NA 6,250 target

Platform of Randomized Adaptive Clinical Trials in Critical Illness

University Health Network, Toronto

NCT05440851
Recruiting NA 6,000 target

CGM for the Early Detection and Management of Hyperglycemia in Pregnancy

Jaeb Center for Health Research

NCT06957028
Recruiting NA 5,076 target

Preventing School Exclusion and Opioid Misuse: Effectiveness of the Inclusive Skill-building Learning Approach (ISLA)

University of Oregon

NCT06292078
Recruiting 5,000 target

ALS/MND Natural History Study Data Repository

Massachusetts General Hospital

NCT05966038
Recruiting 5,000 target

Cardiogenic Shock Working Group Registry

Tufts Medical Center

NCT04682483
Recruiting 5,000 target

Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic Disease

The University of Texas Health Science Center, Houston

NCT04005976
Recruiting 5,000 target

The Parkinson's Genetic Research Study

University of Washington

NCT01558479
Recruiting NA 4,000 target

Reaching Out to Distressed Medical Residents, Fellows and Faculty

Oregon Health and Science University

NCT02010866
Recruiting NA 4,000 target

Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD

Seattle Institute for Biomedical and Clinical Research

NCT05718102
Recruiting Phase 1 3,000 target

Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

Beat AML

NCT03013998
Recruiting 3,000 target

Diaphragmatic Hernia Research & Exploration, Advancing Molecular Science

Columbia University

NCT00950118
Recruiting 3,000 target

EXtubation Related Complications - the EXTUBE Study (EXTUBE)

University Health Network, Toronto

NCT06442930
Recruiting NA 2,529 target

Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response

VA Office of Research and Development

NCT04142177
Recruiting 2,500 target

Total Shoulder Arthroplasty Multi-Center Registry

Arthrex

NCT03511586
Recruiting NA 2,300 target

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

Massachusetts General Hospital

NCT05237258
Recruiting NA 2,009 target

LITES Task Order 0005 Prehospital Airway Control Trial (PACT)

Jason Sperry

NCT04100564
Recruiting 2,000 target

HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry

University of Kansas Medical Center

NCT06425848
Recruiting 2,000 target

Clinical and Genetic Analysis of ROP

Oregon Health and Science University

NCT04420156
Recruiting 2,000 target

Glycemic Metrics and Patterns in People With and Without Prediabetes

Abbott Diabetes Care

NCT06921902
Recruiting NA 2,000 target

Confirmatory Trial for Alleviating Fatigue in Multiple Sclerosis

Accelerated Cure Project for Multiple Sclerosis

NCT06441617
Recruiting 2,000 target

Precision-Based Genomics in Prostate Cancer

National Cancer Institute (NCI)

NCT04706663
Recruiting NA 1,872 target

Evaluation of Aim to Play, a User-Friendly Digital Application for Teacher Skills Training and Physical Education Activities for 3-5 Grade Students

Saavsus

NCT07203313
Recruiting 1,600 target

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Duke University

NCT03511118
Recruiting 1,500 target

Longitudinal Study of Urea Cycle Disorders

Andrea Gropman

NCT00237315
Recruiting 1,500 target

Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain

Boston Scientific Corporation

NCT06827262
Recruiting 1,500 target

Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants

Jaeb Center for Health Research

NCT05589714
Recruiting Phase 4 1,404 target

Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start

University of Utah

NCT05444582
Recruiting Phase 4 1,335 target

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

Mayo Clinic

NCT06972056
Recruiting 1,332 target

Waveform Capnography Compared to Colorimetric Carbon Dioxide Detection During Tracheal Intubation of Critically Ill Adults

Brian Driver

NCT06934876
Recruiting Phase 3 1,300 target

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Kura Oncology

NCT07007312
Recruiting NA 1,270 target

SBIR/ STTR Family Check-up Online

University of Oregon

NCT06876246
Recruiting NA 1,260 target

Mediators and Moderators of Auditory Training

Northeastern University

NCT06812273
Recruiting 1,200 target

Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas

University of Michigan Rogel Cancer Center

NCT00843375
Recruiting 1,200 target

Clinical Procedures to Support Research in ALS

University of Miami

NCT03489278
Recruiting Phase 1 1,200 target

Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)

Merck Sharp & Dohme

NCT02861573
Recruiting Phase 3 1,100 target

Trauma Resuscitation With Low-Titer Group O Whole Blood or Products

University of Alabama at Birmingham

NCT05638581
Recruiting NA 1,100 target

HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial

Population Health Research Institute

NCT04743765
Recruiting Phase 3 1,100 target

Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome

Beth Israel Deaconess Medical Center

NCT06066502
Recruiting 1,060 target

Treatment With Endovascular Intervention for STroke Patients With Existing Disability

University of Cincinnati

NCT05911568
Recruiting NA 1,040 target

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

University of Calgary

NCT05219110
Recruiting NA 1,000 target

Narrow Excision Versus Wide Excision for the Treatment of Adults With Invasive Cutaneous Melanoma, ICEMAN Trial

OHSU Knight Cancer Institute

NCT06673095
Recruiting 1,000 target

Beat Childhood Cancer Specimen Banking and Data Registry

Giselle Sholler

NCT04715178
Recruiting 1,000 target

Retrospective Acute Care Appendectomy Study

Intuitive Surgical

NCT06624215
Recruiting 1,000 target

Mitral Valve Screening Survey

Medstar Health Research Institute

NCT04736667
Recruiting NA 1,000 target

First Face Training Evaluation in Tribal Communities

Cambridge Health Alliance

NCT05998005
Recruiting 1,000 target

BBD Longitudinal Study of Osteogenesis Imperfecta

Baylor College of Medicine

NCT02432625
Recruiting Phase 3 1,000 target

Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children

Philip Spinella

NCT06070350
Recruiting Phase 2 982 target

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Pfizer

NCT06989437
Recruiting NA 960 target

ICBT (Internet Based Cognitive Behavioral Therapy) for Maternal Depression: Community Implementation in Head Start

Oregon Research Institute

NCT05142384
Recruiting Phase 1 949 target

A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors

Bristol-Myers Squibb

NCT04895709
Recruiting NA 900 target

FAmily Engagement Strategy for Coordinated Specialty Care

Washington State University

NCT06945055
Recruiting 850 target

JUPITER 4.0 - Risk Factors for Failure of Isolated Medial Patellofemoral Ligament Reconstruction

Hospital for Special Surgery, New York

NCT06883396
Recruiting 850 target

Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib

Pfizer

NCT06531109
Recruiting Phase 3 825 target

MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma

AstraZeneca

NCT06097728
Recruiting Phase 3 815 target

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

Merck Sharp & Dohme

NCT07218029
Recruiting Phase 3 800 target

Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)

AstraZeneca

NCT06079671
Recruiting Phase 3 800 target

A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Pfizer

NCT07222800
Recruiting 800 target

Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment

Montefiore Medical Center

NCT06033274
Recruiting Phase 3 800 target

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

Janssen Research & Development

NCT07225946
Recruiting Phase 3 790 target

Clarifying the Optimal Application of SLT Therapy Trial

University of Pittsburgh

NCT04967989
Recruiting Phase 3 770 target

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Merck Sharp & Dohme

NCT06824467
Recruiting Phase 3 735 target

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

Merck Sharp & Dohme

NCT05947851
Recruiting Phase 3 726 target

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

Daiichi Sankyo

NCT06731478
Recruiting Phase 3 720 target

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

Arcus Biosciences

NCT07011719
Recruiting Phase 1 720 target

First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Eli Lilly and Company

NCT05768139
Recruiting NA 710 target

Randomized Controlled Effectiveness Trial of VA S.A.V.E.

VA Office of Research and Development

NCT06470867
Recruiting Phase 1 695 target

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

AstraZeneca

NCT05417594
Recruiting 690 target

Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence Tomography

Oregon Health and Science University

NCT00532051
Recruiting Phase 2 690 target

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Bristol-Myers Squibb

NCT07221149
Recruiting Phase 3 686 target

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

Daiichi Sankyo

NCT06899126
Recruiting Phase 1 681 target

A Study of ASP3082 in Adults With Advanced Solid Tumors

Astellas Pharma

NCT05382559
Recruiting 680 target

A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

argenx

NCT06298565
Recruiting Phase 3 675 target

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

AbbVie

NCT06461897
Recruiting Phase 3 663 target

A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

Janssen Research & Development

NCT07164443
Recruiting 660 target

Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study

University of Wisconsin, Madison

NCT05677880
Recruiting Phase 2 660 target

A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

AbbVie

NCT07095452
Recruiting Phase 3 659 target

Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.

Granata Bio Corporation

NCT07216742
Recruiting NA 640 target

STELLA-FTD: Examination of a Behavior Change Intervention for FTD Family Care Partners

Oregon Health and Science University

NCT06613204
Recruiting 640 target

Placental Risk Assessment to CusTomize Individualized Pregnancy Care and Evaluation

Oregon Health and Science University

NCT07144839
Recruiting Phase 2 630 target

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Daiichi Sankyo

NCT07129993
Recruiting NA 620 target

Virtual Tai ji Quan Exercise to Prevent Falls in Older Adults

Oregon Research Institute

NCT05822466
Recruiting Phase 3 614 target

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

Merck Sharp & Dohme

NCT06170788
Recruiting Phase 3 608 target

Tele-Collaborative Outreach to Rural Patients With Chronic Pain

Oregon Health and Science University

NCT06091202
Recruiting Phase 4 606 target

Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)

Oregon Health and Science University

NCT02342444
Recruiting Phase 3 600 target

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Hoffmann-La Roche

NCT06793215

Read our methodology - how recruiting status is sourced and refreshed from the public registry.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Recruiting status is reported by each study's sponsor and mirrored from the public registry. Always confirm current eligibility and status on ClinicalTrials.gov before contacting a study.

Verify with NIH →